Impact of a combined continuous glucose monitoring-digital health solution on glucose metrics and self-management behavior for adults with type 2 diabetes: real-world, observational study
Open accessPublished version of a preprint
The DOI matches its Crossref record; 20 of the 20 references it cites were found in a registry or an index.
Abstract
Background: The BlueStar (Welldoc) digital health solution for people with diabetes incorporates data from multiple devices and generates coaching messages using artificial intelligence. The BlueStar app syncs glucose data from the G6 (Dexcom) real-time continuous glucose monitoring (RT-CGM) system, which provides a glucose measurement every 5 minutes. Objective: The objective of this real-world study of people with type 2 diabetes (T2D) using the digital health solution and RT-CGM was to evaluate change in glycemic control and engagement with the program over 3 months. Methods: Participants were current or former enrollees in an employer-sponsored health plan, were aged 18 years or older, had a T2D diagnosis, and were not using prandial insulin. Outcomes included CGM-based glycemic metrics and engagement with the BlueStar app, including logging medications taken, exercise, food details, blood pressure, weight, and hours of sleep. Results: Participants in the program that met our analysis criteria (n=52) were aged a mean of 53 (SD 9) years; 37% (19/52) were female and approximately 50% (25/52) were taking diabetes medications. The RT-CGM system was worn 90% (SD 8%) of the time over 3 months. Among individuals with suboptimal glycemic control at baseline, defined as mean glucose >180 mg/dL, clinically meaningful improvements in glycemic control were observed, including reductions in a glucose management indicator (–0.8 percentage points), time above range 181-250 mg/dL (–4.4 percentage points) and time above range >250 mg/dL (–14 percentage points; all P<.05). Time in range 70-180 mg/dL also increased by 15 percentage points (P=.016) in this population, which corresponds to an increase of approximately 3.5 hours per day in the target range. Over the 3-month study, 29% (15/52) of participants completed at least one engagement activity per week. Medication logging was completed most often by participants (23/52, 44%) at a rate of 12.1 (SD 0.8) events/week, and this was closely followed by exercise and food logging. Conclusions: The combination of an artificial intelligence–powered digital health solution and RT-CGM helped people with T2D improve their glycemic outcomes and diabetes self-management behaviors.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“However, in a real-world observational study in individuals with type 2 diabetes treated with basal insulin, oral medications, or no medications, the use of a digital health solution and rtCGM resulted in reductions of GMI and TAR >180 and >250 mg/dL as well as an increase in TIR by 15% and participation in a least one engagement activity per week (274).”
From 7. Diabetes Technology: Standards of Care in Diabetes—2025 (2025) · cites this paper as [274]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Battelino, T., Danne, T., Bergenstal, R. M., Amiel, S. A., Beck, R., Biester, T., Bosi, E., Buckingham, B. A., Cefalu, W. T., Close, K. L., et al. (2019) · Diabetes Care · doi:10.2337/dci19-0028 · Cited by 4,237
Glucose management indicator (GMI): a new term for estimating A1C from continuous glucose monitoring
Bergenstal, R. M., Beck, R. W., Close, K. L., Grunberger, G., Sacks, D. B., Kowalski, A., Brown, A. S., Heinemann, L., Aleppo, G., Ryan, D. B., et al. (2018) · Diabetes Care · doi:10.2337/dc18-1581 · Cited by 684
Quinn, C. C., Shardell, M. D., Terrin, M. L., Barr, E. A., Ballew, S. H., & Gruber-Baldini, A. L. (2011) · Diabetes Care · doi:10.2337/dc11-0366 · Cited by 650
Greenwood, D. A., Gee, P. M., Fatkin, K. J., & Peeples, M. (2017) · Journal of Diabetes Science and Technology · doi:10.1177/1932296817713506 · Cited by 526 · cited 1×
“Systematic reviews found that the majority of technology-enabled diabetes management interventions are associated with HbA 1C reductions [5,6] and can improve self-efficacy, leading to greater self-confidence [5].”
7. Diabetes Technology: Standards of Care in Diabetes — 2023
ElSayed, N. A., Aleppo, G., Aroda, V. R., Bannuru, R. R., Brown, F. M., Bruemmer, D., Collins, B. S., Hilliard, M. E., Isaacs, D., Johnson, E. L., et al. (2023) · Diabetes Care · doi:10.2337/dc23-s007 · Cited by 301
Bonoto, B. C., de Araújo, V. E., Godói, I. P., de Lemos, L. L. P., Godman, B., Bennie, M., Diniz, L. M., & Junior, A. A. G. (2017) · JMIR mhealth and uhealth · doi:10.2196/mhealth.6309 · Cited by 294 · cited 1×
“Systematic reviews found that the majority of technology-enabled diabetes management interventions are associated with HbA 1C reductions [5,6] and can improve self-efficacy, leading to greater self-confidence [5].”
An Effective Model of Diabetes Care and Education: The ADCES7 Self-Care Behaviors™
Association of Diabetes Care and Education Specialists, & Kolb, L. (2021) · The Science of Diabetes Self-Management and Care · doi:10.1177/0145721720978154 · Cited by 246
Shamanna, P., Saboo, B., Damodharan, S., Mohammed, J., Mohamed, M., Poon, T., Kleinman, N. L., & Thajudeen, M. (2020) · Diabetes Therapy · doi:10.1007/s13300-020-00931-w · Cited by 123 · cited 3×
“Studies of these programs have reported glycemic and other outcomes; however, it is not possible to directly compare the results to those in this study due to differences in the program models for delivering diabetes educational support and coaching, live clinician management, and CGM wear patterns (continuous vs inte…”
BackgroundResultBergenstal, R. M., Layne, J. E., Zisser, H., Gabbay, R. A., Barleen, N. A., Lee, A. A., Majithia, A. R., Parkin, C. G., & Dixon, R. F. (2021) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2020.0396 · Cited by 110 · cited 3×
“Participants in telehealth programs that incorporated RT-CGM reported an increased understanding of their diabetes [13], lower diabetes distress [16,18], and improved quality of life [16].”
Self-citationReviewing U.S. connected diabetes care: the newest member of the team
Levine, B. J., Close, K. L., & Gabbay, R. A. (2020) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2019.0273 · Cited by 66 · cited 1×
“In recent years, digital health solutions that aim to improve the lives of people with T2D have grown in both number and scale [3].”
Cited by
7. Diabetes Technology: Standards of Care in Diabetes—2025
American Diabetes Association Professional Practice Committee, ElSayed, N. A., McCoy, R. G., Aleppo, G., Balapattabi, K., Beverly, E. A., Briggs Early, K., Bruemmer, D., Echouffo-Tcheugui, J. B., Ekhlaspour, L., et al. (2025) · Diabetes Care · doi:10.2337/dc25-s007 · Cited by 348
7. Diabetes Technology: Standards of Care in Diabetes—2026
Bajaj, M. S., McCoy, R. G., Balapattabi, K., Bannuru, R. R., Bellini, N. J., Bennett, A. K., Beverly, E. A., Early, K. B., ChallaSivaKanaka, S., Echouffo-Tcheugui, J. B., et al. (2025) · Diabetes Care · doi:10.2337/dc26-s007 · Cited by 279
Artificial intelligence for diabetes care: current and future prospects
Sheng, B., Pushpanathan, K., Guan, Z., Lim, Q. H., Lim, Z. W., Yew, S. M. E., Goh, J. H. L., Bee, Y. M., Sabanayagam, C., Sevdalis, N., et al. (2024) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(24)00154-2 · Cited by 106
AI Applications for Chronic Condition Self-Management: Scoping Review
Hwang, M., Zheng, Y., Cho, Y., & Jiang, Y. (2025) · Journal of Medical Internet Research · doi:10.2196/59632 · Cited by 71
“Only 31% (4/13) of the studies conducted field testing [19,55,90,92].”
Hietbrink, E. A. G., Lansink, C., Laverman, G. D., Vollenbroek-Hutten, M. M. R., Middelweerd, A., & Tabak, M. (2025) · npj Digital Medicine · doi:10.1038/s41746-025-02054-7 · Cited by 26
“Expanding such monitoring could make the relevance of behavior change more tangible and motivating by providing direct feedback on healthoutcomes that matter topatients 80,81 .”
Metadata
- Authors
- Kumbara, A. B., Iyer, A. K., Green, C. R., Jepson, L. H., Leone, K., Layne, J. E., & Shomali, M.
- Affiliations
- Dexcom (United States) (US)
- Corresponding author
- Shomali, Mansur
- ORCID
- Venue
- JMIR Diabetes
- Publisher
- JMIR Publications Inc.
- Published
- 2023-09-11
- Volume
- 8
- Pages
- e47638
- ISSN
- 2371-4379 (ISSN-L)
- PMC
- PMC10520761
- OpenAlex
- W4385852268
- Cited by
- 29
- References
- 20
- Citations by year
- 2026: 9 · 2025: 16 · 2024: 4
- FWCI
- 5.95
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- cc-by
- Locations
- JMIR Diabetes (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Funders
- Dexcom
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Research
- Health Sciences › Health Professions › General Health Professions › Mobile Health and mHealth Applications
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Education
- Keywords
- type 2 diabetes, continuous glucose monitoring, digital health interventions, glycemic control, glucose management indicator, time in range, time above range, self-management behavior, user engagement, employer-sponsored health insurance, Dexcom G6, real-world evidence, mobile health apps, food logging
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.
